The effect of oral product containing amla fruit on women’s androgenic alopecia

Phase 3

• Conditions: Androgenic alopecia.; Androgenic alopecia, unspecified; L64.9

• Registration Number: IRCT20201010048979N2
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Women aged 18 to 60 years old
Type 1 to 2 hair loss according to the Hamilton Hair Loss Criterion that has lasted more than 6 months
Patient consent approval to participate in the study

Exclusion Criteria

Records of using any typical products to prevent hair loss or stimulate hair growth in the past 2 months
Utilizing 5 a reductase inhibitors in the past 2 months
Records of taking anti-androgenic drugs in the past 2 months
Records of systemically taken steroids for more than 14 days in the past 2 months
Any active diseases in the head including scalp infection in the past 6 months
Records of any types of cancer or autoimmune diseases
Any records of hair transplantation
Pregnancy and lactation
The history of underlying diseases of diabetes, hypothyroidism, polycystic ovary syndrome
The history of acute illness in the last 2 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of hair strands. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Terminal hair to Volos hair. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Ratio of anagen to telogen hair. Timepoint: Before intervention, 12 weeks after the intervention. Method of measurement: Trichoscan.;Physician satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire.;Patient satisfaction with treatment. Timepoint: Before intervention, 6 and 12 weeks after the intervention. Method of measurement: questionnaire.